MINIMAL CHANGE DISEASE AND ACUTE TUBULAR NECROSIS CAUSED BY DICLOFENAC
KRESIMIR GALESIC,
KRESIMIR GALESIC
Departments of Internal Medicine and
Search for more papers by this author DANICA LJUBANOVIC,
DANICA LJUBANOVIC
Pathology, Dubrava University Hospital, Zagreb, Croatia
Search for more papers by this author STELA BULIMBASIC,
STELA BULIMBASIC
Pathology, Dubrava University Hospital, Zagreb, Croatia
Search for more papers by this author IVANA RACIC,
IVANA RACIC
Departments of Internal Medicine and
Search for more papers by this author
KRESIMIR GALESIC,
KRESIMIR GALESIC
Departments of Internal Medicine and
Search for more papers by this author DANICA LJUBANOVIC,
DANICA LJUBANOVIC
Pathology, Dubrava University Hospital, Zagreb, Croatia
Search for more papers by this author STELA BULIMBASIC,
STELA BULIMBASIC
Pathology, Dubrava University Hospital, Zagreb, Croatia
Search for more papers by this author IVANA RACIC,
IVANA RACIC
Departments of Internal Medicine and
Search for more papers by this author
First published: 10 January 2008
No abstract is available for this article.
REFERENCES
- 1
Clive DM,
Stoff JS.
Renal syndromes associated with non-steroidal anti-inflammatory drugs.
N. Engl. J. Med.
1984; 310: 563–72.
- 2
Levy M,
Rondeau E,
Lleu-Nahmias G,
Mougenont B,
Staer JD.
Severe nephrotic syndrome with acute renal failure after fenbufen.
Clin. Nephrol.
1987; 28: 103–4.
- 3
Gambaro G,
Parazella MA.
Adverse renal effects of anti-inflammatory agents: evaluation of selective and non-selective cyclooxygenase inhibitors.
J. Intern. Med.
2003; 253: 643–52.
- 4
Harris RC.
COX-2 and the kidney.
J. Cardiovasc. Pharmacol.
2006; 47: S37–S42.
